Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Cancers|March 13, 2024
Real-World Data on Clinical Outcomes and Treatment Management of Advanced Melanoma Patients: Single-Center Study of a Tertiary Cancer Center in SwitzerlandRamon Staeger, Julia M Martínez-Gómez, Patrick Turko, et al.
International Journal of Molecular Sciences|September 14, 2024
Distinct Variations in Gene Expression and Cell Composition across Lichen Planus SubtypesCadri Knoch, Veronika Baghin, Patrick Turko, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 14, 2023
The impact of the COVID-19 pandemic on the diagnosis of cutaneous melanomas: A retrospective cohort study from five European skin cancer reference centresAlexander Troesch, Magdalena Hoellwerth, Stephan Forchhammer, et al.
Cancers|June 26, 2025
Immune-Related Cutaneous Adverse Events Display Distinct Clinical and Molecular Characteristics, Depending on Immune Checkpoints TargetedLukas Kraehenbuehl, Nicola Winkelbeiner, Patrick Turko, et al.
The British Journal of Dermatology|June 25, 2024
COL10A1 expression distinguishes a subset of cancer-associated fibroblasts present in the stroma of high-risk basal cell carcinomaMauro Esposito, Laura Yerly, Prachi Shukla, et al.
Cancer Research|October 14, 2021
Specific Activation of the CD271 Intracellular Domain in Combination with Chemotherapy or Targeted Therapy Inhibits Melanoma ProgressionAnnalisa Saltari, Andreas Dzung, Marika Quadri, et al.
Cancer Research|September 20, 2023
Combinatorial Treatment with PARP and MAPK Inhibitors Overcomes Phenotype Switch-Driven Drug Resistance in Advanced MelanomaLorenza P Ferretti, Flurina Böhi, Deena M Leslie Pedrioli, et al.
The Journal of Clinical Investigation|May 1, 2025
Tebentafusp elicits on-target cutaneous immune responses driven by cytotoxic T-cells in uveal melanoma patientsRamon Staeger, Aizhan Tastanova, Adhideb Ghosh, et al.
Molecular Cancer Research : MCR|April 18, 2023
MDM2 Inhibition Enhances Immune Checkpoint Inhibitor Efficacy by Increasing IL15 and MHC Class II ProductionMarlene Langenbach, Sophie Giesler, Stefan Richtsfeld, et al.
The EMBO Journal|May 26, 2026
NGFR induces melanoma invasion and immunotherapy resistance through myosin light chain 2 modulationLaura Nogués, Vanesa Santos, Juan García-Agullo, et al.
Pageof 4